Possessing platform technologies for new modified drugs
Overview
Luphere Depot Injection is specially designed for sustained release over a longer duration compared to normal formulations, and helps obtain better clinical results by administering to patients with poor drug compliance.
Possessed Technologies
Microsphere spray-dry technology
Microsphere emulsion technology
Nano/micro suspension technology
Gel-core microsphere technology
Injection container, Dual Chamber Syringe (DCS) development
Distinguishing Point
Spray-dry type possessing microsphere manufacturing patent
Possession of equipment and platform technologies for research and production
Development of an exclusive injection container (DCS) for increased convenience and possession of automatic charging equipment
Nano Dispersion in Solid Lipid
Lipid Removal with SCF
* Original technology of BioSynetics
Overview
Technology for turning solid active materials into nanoparticles using carbon dioxide
By adjusting the particle size of a drug in nanometers (1/10billion m), it can be used to make non- soluble (where substances do not melt in solvents) be available for drugs.
This technology improves stability by overcoming stability issues such as aggregation and recrystallization of normal solubilization technologies
Production process is simplified and made through minimization of polymer use. (self-production possible)
Technological Effects
Improves bioavailability, changes method, dose and formulation, reduces before-and after meal deviations, reduces toxicity
Overview
This technology enables fabricating two or more different types of medicine or drugs with a quick effect and a lasting effect combined in a single capsule.
Different types of small-sized tablets can be charged in a single capsule simultaneously.
Different drugs can be configured each with its ideal release pattern.
Drugs are placed in a capsule, avoiding physical contact, and therefore maximizing stability.
Overview
The release pattern of complex drugs can be adjusted by filling various drug formulations such as pellet, tablets and liquids in a single capsule.
Ideal combination drug development is made possible while also procuring stability.
